NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) »
04/12/14

Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Ofa First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkina€™s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) »
04/21/14

Extensive High-Depth Sequencing Of Longitudinal CLL Samples Identifies Frequent Mutations In MAP Kinase Signaling and Novel Mutations Activating Notch and Beta-Catenin »
04/21/14

The Co-Culture Of Primary CLL Cells »
04/27/14

Impact Of The Number Of Prior Treatment »
04/27/14

NOTCH1 Mutation and Treatment Outcome »
04/27/14

A Phase I Study Of The Oral Btk Inhibitor »
04/27/14

The Brutona€™s Tyrosine Kinase (BTK) Inhibitor »
04/27/14

Increased Local Disorder of DNA Methylation »
04/27/14

A Phase II Multi-Center Trial »
04/27/14